University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 12 of 15
Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid
NCT01350024
Evaluating Whole Foods Supplementation on Cognition
NCT01672359
A Personalized Reminder Information and Social Management System
NCT01497613
Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer
NCT01313039
A Novel Fully Integrated Mobile Management Solution Using Cell Phone Technology for Heart Failure
NCT02935439
Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial
NCT01823250
The Effect of Methylated Vitamin B Complex on Depression
NCT01672372
Nebivolol Versus Metoprolol: Sodium Sensitivity
NCT00992056
Family Intervention for Teen Drinking in the ER
NCT01229748
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
NCT01245101
Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma
NCT01210170
Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process
NCT01650636
Pilot Study of Fenofibrate for PSC
NCT01142323
Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)
NCT01467817
Diurnal Variation of Tear Meniscus and Tear Osmolarity
NCT01206244
Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris
NCT01193764
Familias Unidas: Preventing Substance Abuse in Hispanic Youth
NCT01038206
Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors
NCT01152957
Hydrolized Protein Formula for Premature Infants
NCT01156493
Microparticles in Stored RBC as Potential Mediators of Transfusion Complications
NCT01185600
Interrogation of Wnt, Notch and Hedgehog Activity in Primary Tumor Samples
NCT02006550
Improving Adherence to Statins Among Minority Populations
NCT02037685
Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
NCT02012777
A Comparison Study of the Tensile Strength of Sutures Used in Dermatologic Surgery on the Day of Suture Removal, Following Wound Care With Two Different Products
NCT01533675
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
NCT02198079
The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)
NCT01087996
6 Minute Push & 30 Second Sprint Tests Reliability & Relationship to Fitness, Participation, & Environmental Assessments
NCT01184742
Cardiometabolic Risk, Obesity and Cardiovascular Disease in People With Spinal Cord Injury
NCT01204632
FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
NCT03627806
Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations
NCT01651208
Juvenile Offender HIV Prevention and Drug Abuse Services
NCT01922297
Clinical Evidence of pH Dependent ß2 Adrenergic Transport Mechanisms in the Airway
NCT01216748
Immunogenicity of Inactivated Swine H1N1 Vaccine In HIV Infected Children - The Miami Cohort Study
NCT02031874
Enhanced Natural Killer Cell Activity and RBAC
NCT02019628
Effect of Whole Body Periodic Acceleration on Airway Endothelial Function
NCT01213706
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
NCT00772668
Familias Unidas: Preventing Drug Abuse and HIV in Hispanic First Offenders
NCT01257022
A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
NCT00955721
Effects of Salsalate on Prandial-Induced Vascular Inflammation After Spinal Cord Injury (SCI)
NCT01201759
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
NCT01209520
Defining Normal Citrulline Levels as a Diagnostic Tool for Screening of Gastrointestinal Disease in Premature Infants
NCT01062828
Preventing Adolescents From Entering the Juvenile Justice System
NCT02147743
Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
NCT01964755
Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma
NCT00878254
Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease
NCT02034318
Racial Differences in Phosphorus Metabolism
NCT00856726
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
NCT01062815
Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
NCT00706147
Rapid HIV Testing and Counseling in Drug Abuse Treatment
NCT00809445
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
NCT00534209
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Miami pipeline card: 721 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.